Case report: A patient coinfected by Borrelia burgdorferi sensu lato and spotted fever group Rickettsiae in Urumqi, China

Medicine (Baltimore). 2019 Nov;98(46):e17977. doi: 10.1097/MD.0000000000017977.

Abstract

Rationale: Both Borrelia burgdorferi sensu lato and spotted fever group Rickettsiae (SFGR) are pathogens carried by ticks. There is a possibility of co-infection with these tick-borne diseases.

Patient concerns: Male patient, 63 years-of-age, admitted to hospital with skin rash presenting for 1 week and fever with cough and expectoration for 3 days before admission.

Diagnoses: We diagnosed that the patient was co-infected by B burgdorferi sl and SFGR using laboratory test results and the patient's clinical manifestations.

Interventions: The patient started therapy with oral minocycline, then levofloxacin by intravenous injection for SFGR. Meanwhile, he was treated with penicillin G sodium, cefoperazone sulbactam sodium and ceftriaxone by intravenous injection for B burgdorferi sl.

Outcomes: After the patient was in stable condition, he was discharged from hospital.

Lessons: This case report highlights the possibility of co-infection by 2 tick-borne diseases in Urumqi, Xinjiang Uygur Autonomous Region, China. The antibiotic therapy should be based on the detection of pathogenic bacteria, and the different susceptibilities of co-infecting bacteria should be considered.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Borrelia burgdorferi
  • China
  • Humans
  • Lyme Disease / complications*
  • Lyme Disease / drug therapy
  • Male
  • Middle Aged
  • Polymerase Chain Reaction
  • Spotted Fever Group Rickettsiosis / complications*
  • Spotted Fever Group Rickettsiosis / drug therapy
  • Tick-Borne Diseases / complications*
  • Tick-Borne Diseases / drug therapy

Substances

  • Anti-Bacterial Agents